Morgan Stanley’s CHINA NEPSTAR CHAIN DRUGSTORE LTD. COM NPD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-123,258
Closed -$300K 6699
2016
Q2
$300K Buy
123,258
+5,000
+4% +$12.3K ﹤0.01% 4729
2016
Q1
$292K Buy
118,258
+73,637
+165% +$171K ﹤0.01% 4761
2015
Q4
$109K Buy
44,621
+23,190
+108% +$54.8K ﹤0.01% 5361
2015
Q3
$46K Buy
21,431
+20,996
+4,827% +$46K ﹤0.01% 5767
2015
Q2
$1K Hold
435
﹤0.01% 6606
2015
Q1
$1K Hold
435
﹤0.01% 6516
2014
Q4
$1K Hold
435
﹤0.01% 6521
2014
Q3
$1K Hold
435
﹤0.01% 6519
2014
Q2
$1K Hold
435
﹤0.01% 6468
2014
Q1
$1K Hold
435
﹤0.01% 6424
2013
Q4
$1K Buy
+435
New +$835 ﹤0.01% 6322
2013
Q3
Sell
-12,335
Closed -$19K 5464
2013
Q2
$19K Buy
+12,335
New +$21.1K ﹤0.01% 5281

Morgan Stanley's NPD Position: Q3 2016 in Review

Morgan Stanley sold out of CHINA NEPSTAR CHAIN DRUGSTORE LTD. COM (NPD) in Q3 2016, closing a stake of 123,258 shares — an estimated $300K sold.

Morgan Stanley first reported a position in NPD in Q2 2013 and held it in 12 quarters. The position peaked at $300K in Q2 2016. 0 funds tracked by Wall St. Rank hold NPD as of Q3 2016.

  • Morgan Stanley reported no remaining CHINA NEPSTAR CHAIN DRUGSTORE LTD. COM position as of Q3 2016 after selling out during the quarter.
  • Morgan Stanley sold 123,258 CHINA NEPSTAR CHAIN DRUGSTORE LTD. COM shares in Q3 2016, an estimated $300K.
  • Morgan Stanley first reported a position in CHINA NEPSTAR CHAIN DRUGSTORE LTD. COM in Q2 2013 and held it in 12 quarters.
  • Morgan Stanley's CHINA NEPSTAR CHAIN DRUGSTORE LTD. COM position peaked at $300K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CHINA NEPSTAR CHAIN DRUGSTORE LTD. COM as of Q3 2016.

Based on Morgan Stanley's 13F filing for Q3 2016, filed 10 Nov 2016.